Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: A hospital-based study from south India

Neurology India

Volumn 58, Issue 3, 2010, Pages 403-406

  Boddu, Demudu ^a   Srinivasarao Bandaru, V C S ^a   Reddy, Prasad ^a   Madhusudan, M ^a   Rukmini, M ^a   Suryaprabha, T ^a   Jabeen, S ^a   Suvarna, A ^a   Jayalakshmi, Sita ^a   Meena, A ^a   Borgohain, Rupam ^a   Kaul, Subhash ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute ischemic stroke; intravenous rt PA; major neurological outcome; mRS

Indexed keywords

ALTEPLASE; GLUCOSE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ALCOHOLISM; AORTA ARCH SYNDROME; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; GLUCOSE BRAIN LEVEL; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INDIA; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTOR VARIABLE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RANKIN SCALE; RISK FACTOR; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; CLASSIFICATION; COMPLICATION; HOSPITAL; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK; STATISTICS AND NUMERICAL DATA; STROKE; TIME; YOUNG ADULT;

ADULT; AGED; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HOSPITALS; HUMANS; INDIA; INJECTIONS, INTRAVENOUS; ISCHEMIA; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955066375     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.66085     Document Type: Article

References (18)

1. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
2. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, et al. Use of tissue- type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151-1158
3. Bravata DM, Kim N, Concato J, Krumholz HM, Brass LM. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002;162:1994-2001.
4. Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke 2004;35:147-150
5. Brandt T, von Kummer R, Müller-Küppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996;27:875-881
6. Molina CA, Montaner J, Abilleira S, Arenillas JF, Ribó M, Huertas R, et al. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case- control study. Stroke 2001;32: 2821-2827
7. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000;31:610-614
8. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, et al. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89-93.
9. Felberg RA, Okon NJ, El-Mitwalli A, Burgin WS, Grotta JC, Alexandrov AV. Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke. Stroke 2002;33:1301-1307
10. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001;103:2897-2902
11. Johnston KC, Connors AF Jr, Wagner DP, Knaus WA, Wang X, Haley EC Jr. A predictive risk model for outcomes of ischemic stroke. Stroke 2000;31:448-455
12. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55:1649-1655
13. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 2005;36:62-65 (Pubitemid 40054176)
14. Saposnik G, Legge SD, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005;65:1169-1174
15. NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS rt-PA stroke trial. Stroke 1997;28:2119-2125
16. Martinez-Vila E, Irimia P. The cost of stroke. Cerebrovasc Dis 2004;17:124-129
17. Saposnik G, Webster F, O'Callaghan C, Hachinski V. Optimizing discharge planning: clinical predictors of longer stay after recombinant tissue plasminogen activator for acute stroke. Stroke 2005;36:147-150.
18. Hacke W, Kaste M, Bluhmki E, Brozman M, Dvalos A, Guidetti D, et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N Engl J Med 2008;59:1317-1329